LOGO.png
IMAC Holdings, Inc. Announces Completion of First Cohort of its Phase 1 Clinical Study of Umbilical Cord-Derived Mesenchymal Stem Cells for the Treatment of Bradykinesia Due to Parkinson’s Disease
March 01, 2021 09:25 ET | IMAC Holdings, Inc.
BRENTWOOD, Tenn, March 01, 2021 (GLOBE NEWSWIRE) -- IMAC Holdings, Inc. (Nasdaq: IMAC) (“IMAC” or “the Company”), today announces it has completed the first cohort of its Phase 1 clinical trial for...
22157.jpg
Global Cord Blood Banking Industry Report 2021: Holding Companies are Emerging as a Global Theme
January 11, 2021 07:38 ET | Research and Markets
Dublin, Jan. 11, 2021 (GLOBE NEWSWIRE) -- The "Global Cord Blood Banking Industry Report 2021" report has been added to ResearchAndMarkets.com's offering. From the early 1900s through the...
22157.jpg
Global Cord Blood Banking Industry Report 2020: Trends, Expansion Technologies, Key Strategies, Regional Insights
August 31, 2020 06:59 ET | Research and Markets
Dublin, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The "Global Cord Blood Banking Industry Report 2020" report has been added to ResearchAndMarkets.com's offering.This report presents the number of cord...
Yarmouth Veterinarian Provides Stem Cell Therapy for Pets
August 31, 2014 07:00 ET | Yarmouth Veterinary Center
YARMOUTH, Maine, Aug. 31, 2014 (GLOBE NEWSWIRE) -- Yarmouth veterinarian Dr. Louise LeBoeuf and her colleagues at Yarmouth Veterinary Center are offering revolutionary stem cell therapy for pets....